Use of a plastic scintillator detector for patient-specific quality assurance of VMAT SRS

Purpose

To evaluate a scintillator detector for patient‐specific quality assurance of VMAT radiosurgery plans.

Methods

The detector was comprised of a 1 mm diameter, 1 mm high scintillator coupled to an acrylic optical fiber. Sixty VMAT SRS plans for treatment of single targets having sizes ranging from 3 mm to 30.2 mm equivalent diameter (median 16.3 mm) were selected. The plans were delivered to a 20 cm × 20 cm x 15 cm water equivalent plastic phantom having either the scintillator detector or radiochromic film at the center. Calibration films were obtained for each measurement session. The films were scanned and converted to dose using a 3‐channel technique.

Results

The mean difference between scintillator and film was ‒0.45% (95% confidence interval ‒0.1% to 0.8%). For target equivalent diameter smaller than the median, the mean difference was 1.1% (95% confidence interval 0.5% to 1.7%). For targets larger than the median, the mean difference was ‒0.2% (95% confidence interval ‒0.7% to 0.1%).

Conclusions

The scintillator detector response is independent of target size for targets as small as 3 mm and is well‐suited for patient‐specific quality assurance of VMAT SRS plans. Further work is needed to evaluate the accuracy for VMAT plans that treat multiple targets using a single isocenter.

Technical Note: Use of automation to eliminate shift errors

Purpose

To create automated tools within the treatment planning system (TPS) that eliminate the common error pathway of providing incorrect shift instructions to therapists.

Materials/Methods

Two scripts were created within the TPS using the Eclipse API (Varian Medical Systems, Palo Alto, CA). One script detects whether or not the user origin has been placed correctly at the intersection of the simulation markers while the other calculates a shift instruction sheet that can be printed for treatment.

Results

Analysis of our RO‐ILS database identified eight errors caused by improper setting of the user origin in the treatment planning system. The user origin script flagged all of the treatment plans for markers inconsistent with user origin. Automated calculation of shifts eliminated the error pathway of miscalculating or transcribing shift values.

Conclusion

Automation can eliminate the common error pathway of providing the wrong shifts to therapists. The scripts have been made available as open‐source software for implementation at other radiotherapy clinics.

Interinstitutional Plan Quality Assessment of 2 Linac-Based, Single-Isocenter, Multiple Metastasis Radiosurgery Techniques

Purpose

Interest and application of stereotactic radiosurgery for multiple brain metastases continue to increase. Various planning systems are available for linear accelerator (linac)–based single-isocenter multiple metastasis radiosurgery. Two of the most advanced systems are BrainLAB Multiple Metastases Elements (MME), a dynamic conformal arc (DCA) approach, and Varian RapidArc (RA), a volumetric modulated arc therapy (VMAT) approach. In this work, we systematically compared plan quality between the 2 techniques.

Methods and Materials

Thirty patients with 4 to 10 metastases (217 total; median 7.5; V_min = 0.014 cm³; V_max = 17.73 cm³) were planned with both Varian RA and MME at 2 different institutions with extensive experience in each respective technique. All plans had a single isocenter and used Varian linac equipped with high-definition multileaf collimator. RA plans used 2 to 4 noncoplanar VMAT arcs with 10 MV flattening filter-free beam. MME plans used 4 to 9 noncoplanar DCAs and 6 MV flattening filter-free beam, (minimum planning target volume [PTV_min] = 0.49 cm³; PTV_max = 27.32 cm³; PTV_median = 7.05 cm³). Prescriptions were 14 to 24 Gy in a single fraction. Target coverage goal was 99% of volume receiving prescription dose (D99% ≥ 100%). Plans were evaluated by Radiation Therapy Oncology Group/Paddick conformity index (CI) score, 12 Gy volume (V_12Gy), V_8Gy, V_5Gy, mean brain dose (D_mean), and beam-on time.

Results

Conformity was favorable among RA plans (median: MME CI^RTOG = 1.38; RA CI^RTOG = 1.21; P < .0001). V_12Gy and V_8Gy were lower for RA plans (median: MME V12 = 23.7 cm³; RA V12 = 19.2 cm³; P = .0001; median: MME V_8Gy = 53.6 cm³; RA V_8Gy = 44.1 cm³; P = .024). V_5Gy was lower for MME plans (median: MME V_5Gy = 141.4 cm³; RA V_5Gy = 142.8 cm³; P = .009). Mean brain was lower for MME plans (median: MME D_mean = 2.57 Gy; RA D_mean = 2.76 Gy; P < .0001).

Conclusions

For linac-based multiple metastasis stereotactic radiosurgery, RapidArc VMAT facilitates favorable conformity and V_12Gy/V_8Gy volume compared with the MME DCA plan. MME planning facilitates reduced dose spill at levels ≤V_5Gy.

Technical Note: An open source solution for improving TG-263 compliance

PURPOSE

Compliance with TG-263 nomenclature standards can be challenging. We introduce an open source solution to this problem and evaluate its impact on compliance within our institution.

MATERIALS/METHODS

The TG-236 nomenclature standards were implemented in our clinic in two phases. In phase 1, we deployed TG-263 compliant templates for each disease site. In phase 2, we developed and deployed a script for evaluating compliance which presented errors to the user. After each phase the compliance was recorded.

RESULTS

Mean compliance errors prior to phase 1 was 31.8% ± 17.4%. Error rates dropped to 8.1% ± 12.2% across phase 1 and dropped further to 2.2% ± 6.9% during the automation system deployed in phase 2.

CONCLUSION

Both structure templates and automation scripts are very useful for increasing compliance with structure naming standards. Our software solution is made available on GitHub for other institutions to implement.

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease

Purpose

Surgery is often used for large or symptomatic brain metastases but is associated with risk of developing leptomeningeal dissemination. Emerging data suggest that fractionated stereotactic radiation therapy (FSRT) is an effective management strategy in large brain metastases. We sought to retrospectively compare leptomeningeal disease (LMD) and local control (LC) rates for patients treated with surgical resection followed by radiosurgery (S + SRS) versus FSRT alone.

Methods and Materials

We identified all patients with a brain metastasis ≥3 cm in diameter treated from 2004 to 2017 with S + SRS or FSRT alone (25 or 30 Gy in 5 fractions) who had follow-up imaging. LMD was defined as focal or diffuse leptomeningeal enhancement that was >5 mm from the index metastasis. Categorical baseline characteristics were compared with the χ² test. LMD and LC rates were evaluated by the Kaplan-Meier (KM) method, with the log-rank test used to compare subgroups.

Results

A total of 125 patients were identified, including 82 and 43 in the S + SRS and FSRT alone groups, respectively. Median pretreatment Graded Prognostic Assessment in the S + SRS and FSRT groups was 2.5 and 1.5, respectively (P < .001). Median follow-up was 7 months. The KM estimate of 12-month LMD rate in the S + SRS and FSRT groups was 45% and 19%, respectively (P = .048). The KM estimate of 12-month local control in the S + SRS and FSRT groups was 70% and 69%, respectively (P = .753). The 12-month KM estimate of grade ≥3 toxicity was 1.4% in S + SRS group versus 6.3% in the FSRT alone group (P = .248). After adjusting for graded prognostic assessment (GPA), no overall survival difference was observed between groups (P = .257).

Conclusions

Surgery is appropriate for certain brain metastases, but S + SRS may increase LMD risk compared with FSRT alone. Because S + SRS and FSRT seem to have similar LC, FSRT may be a viable alternative to S + SRS in select patients with large brain metastases.

Using a whiteboard web application for tracking treatment workflow metrics for dosimetrists and physicians

We present a framework for collecting data which elucidates detailed clinical flow timelines for different treatment sites, modalities, planners, and physicians in radiotherapy treatments. A web based tool, the Whiteboard, was developed which allows communication between the physicians and staff about the current state of the radiotherapy treatment plan and provides detailed time data for each stage of the patient's journey from simulation to treatment. Detailed timestamped data was collected over a period of 6 years which included 22 discrete steps of the treatment planning process. Whiteboard data was combined with data in the treatment planning database Aria (Varian Medical Systems, Palo Alto, CA) using the Eclipse Scripting API to include treatment plan information. Over 6 years, 110,477 patient statuses were time-logged for 9683 courses of treatment using our Whiteboard software, which allowed determination of patient volumes per individual and the time to perform planning tasks. The mean planning volume per dosimetrist was 375.8 ± 142.4 plans and 71.03 ± 27.10 plan revisions per year. The mean planning volume per physician was 218.9 ± 110.8 plan approvals with 41.55 ± 43.73 plan revisions per year. Physician contour time was a mean of 79.59 ± 84.61 hours, but varied greatly by diagnosis category and physician. The longest median modality planning time of 119.6 hours was for the IMRT plans with 8 or more fields. The shortest median times were 48.25, 49.53, and 50.98 hours for plans with 5, 4, and 3 fields, respectively. We demonstrated a framework that could help facilities in staff planning and aid in workload distribution, and could be used to improve understanding of radiotherapy timelines for patients, payers, and other institutions involved in radiotherapy processes.

Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer

Purpose

The aim of this study was to report the treatment planning feasibility of dose escalation to suspicious lymph nodes (LNs) for a series of men who underwent pretreatment [¹⁸F]fluciclovine positron emission tomography (PET)/magnetic resonance imaging (MRI).

Methods and Materials

Cases of men with prostate cancer who enrolled in a clinical trial of pretreatment [¹⁸F]fluciclovine PET who had suspicious LNs were selected. Pelvic LNs <1 cm were defined as positive based on [¹⁸F]fluciclovine-PET if their maximum standardized uptake value (SUV_max) was ≥1.3-fold greater than the reference blood pool SUV_mean, and LNs ≥1 cm were defined as positive if the SUV was greater than the reference SUV bone marrow reference. For each case, a radiation treatment plan was generated to deliver 70 Gy to the prostate and proximal seminal vesicles, 60.2 Gy to the PET-positive LNs, and 50.4 Gy to the elective nodal regions, simultaneously in 28 fractions of 2.5 Gy, 2.15 Gy, and 1.8 Gy, respectively. Treatment planning goals were defined a priori. The resulting target volume and organ-at-risk dosimetry were compared with the original treatment plan.

Results

Four cases were identified, with between 1 and 5 [¹⁸F]fluciclovine PET–positive LNs each. Goals for the prostate and elective nodal target volumes were successfully met in all cases. The goal of covering more than 90% of the positive LN planning target volume by the prescription dose of 60.2 Gy was met in 3 of the 4 cases. This goal was not met in 1 case, but 100% of clinical target volume was covered by 60.2 Gy. The primary organ-at-risk tradeoff was that a small volume (0.5-8.2 cm³) of small bowel would receive ≥54 Gy in each case.

Conclusions

These preliminary results suggest that [¹⁸F]fluciclovine PET/MRI directed dose escalation of suspicious pelvic LNs is likely feasible in the setting of definitive radiation therapy. The potential clinical benefit of dose escalating [¹⁸F]fluciclovine PET–positive LNs should be investigated in a prospective clinical trial.

Optical surface guidance for submillimeter monitoring of patient position during frameless stereotactic radiotherapy

PURPOSE

To evaluate the accuracy of monitoring intrafraction motion during stereotactic radiotherapy with the optical surface monitoring system. Prior studies showing a false increase in the magnitude of translational offsets at non-coplanar couch positions prompted the vendor to implement software changes. This study evaluated two software improvements intended to address false offsets.

METHODS

The vendor implemented two software improvements: a volumetric (ACO) rather than planar calibration and, approximately 6 months later, an improved calibration workflow (CIB) designed to better compensate for thermal drift. Offsets relative to the reference position, obtained at table angle 0 following image-guided setup, were recorded before beam-on at each table position and at the end of treatment the table returned to 0° for patients receiving SRT.

RESULTS

Prior to ACO, between ACO and CIB, and after CIB, 223, 155, and 436 fractions were observed respectively. The median magnitude of translational offsets at the end of treatment was similar for all three intervals: 0.29, 0.33, and 0.27 mm. Prior to ACO, the offset magnitude for non-zero table positions had a median of 0.79 mm and was found to increase with increasing distance from isocenter to the anterior patient surface. After ACO, the median magnitude was 0.74 mm, but the dependence on surface-to-isocenter distance was eliminated. After CIB, the median magnitude for non-zero table positions was reduced to 0.57 mm.

CONCLUSION

Ongoing improvements in software and calibration procedures have decreased reporting of false offsets at non-zero table angles. However, the median magnitude for non-zero table angles is larger than that observed at the end of treatment, indicating that accuracy remains better when the table is not rotated.

Stereotactic radiosurgery with MLC-defined arcs: Verification of dosimetry, spatial accuracy, and end-to-end tests

Purpose

To measure dosimetric and spatial accuracy of stereotactic radiosurgery (SRS) delivered to targets as small as the trigeminal nerve (TN) using a standard external beam treatment planning system (TPS) and multileaf collimator‐(MLC) equipped linear accelerator without cones or other special attachments or modifications.

Methods

Dosimetric performance was assessed by comparing computed dose distributions to film measurements. Comparisons included the γ‐index, beam profiles, isodose lines, maximum dose, and spatial accuracy. Initially, single static 360° arcs of MLC‐shaped fields ranging from 1.6 × 5 to 30 × 30 mm² were planned and delivered to an in‐house built block phantom having approximate dimensions of a human head. The phantom was equipped with markings that allowed accurate setup using planar kV images. Couch walkout during multiple‐arc treatments was investigated by tracking a ball pointer, initially positioned at cone beam computed tomography (CBCT) isocenter, as the couch was rotated. Tracks were mapped with no load and a 90 kg stack of plastic plates simulating patient treatment. The dosimetric effect of walkout was assessed computationally by comparing test plans that corrected for walkout to plans that neglected walkout. The plans involved nine 160° arcs of 2.4 × 5 mm² fields applied at six different couch angles. For end‐to‐end tests that included CT simulation, target contouring, planning, and delivery, a cylindrical phantom mimicking a 3 mm lesion was constructed and irradiated with the nine‐arc regimen. The phantom, lacking markings as setup aids was positioned under CBCT guidance by registering its surface and internal structures with CTs from simulation. Radiochromic film passing through the target center was inserted parallel to the coronal and the sagittal plane for assessment of spatial and dosimetric accuracy.

Results

In the single‐arc block phantom tests computed maximum doses of all field sizes agreed with measurements within 2.4 ± 2.0%. Profile widths at 50% maximum agreed within 0.2 mm. The largest targeting error was 0.33 mm. The γ‐index (3%, 1 mm) averaged over 10 experiments was >1 in only 1% of pixels for field sizes up to 10 × 10 mm² and rose to 4.4% as field size increased to 20 × 20 mm². Table walkout was not affected by load. Walkout shifted the target up to 0.6 mm from CBCT isocenter but, according to computations shifted the dose cloud of the nine‐arc plan by only 0.16 mm. Film measurements verified the small dosimetric effect of walkout, allowing walkout to be neglected during planning and treatment. In the end‐to‐end tests average and maximum targeting errors were 0.30 ± 0.10 and 0.43 mm, respectively. Gamma analysis of coronal and sagittal dose distributions based on a 3%/0.3 mm agreement remained <1 at all pixels. To date, more than 50 functional SRS treatments using MLC‐shaped static field arcs have been delivered.

Conclusion

Stereotactic radiosurgery (SRS) can be planned and delivered on a standard linac without cones or other modifications with better than 0.5 mm spatial and 5% dosimetric accuracy.

Assessing the feasibility of single target radiosurgery quality assurance with portal dosimetry

Purpose

To assess the feasibility of using portal dosimetry (PD) for pre‐treatment quality assurance of single target, flattening filter free (FFF), volumetric arc therapy intracranial radiosurgery plans.

Methods

A PD algorithm was created for a 10X FFF beam on a Varian Edge linear accelerator (Varian Inc, Palo Alto, CA, USA). Treatment plans that were previously evaluated with Gafchromic EBT‐XD (Ashland, Bridgewater, NJ, USA) film were measured via PD and analyzed with the ARIA Portal Dosimetry workspace. Absolute dose evaluation for film and PD was done by computing the mean dose in the region receiving greater than or equal to 90% of the max dose and comparing to the mean dose in the same region calculated by the treatment planning system (TPS). Gamma analysis with 10% threshold and 3%/2 mm passing criteria was performed on film and portal images.

Results

Thirty‐six PD verification plans were delivered and analyzed. The average PD to TPS dose was 0.989 ± 0.01 while film to TPS dose was 1.026 ± 0.01. All PD plans passed the gamma analysis with 100% of points having gamma <1. Overall, PD to TPS dose agreement was found to be target size dependent. As target size decreases, PD to TPS dose ratio decreased from 1.004 for targets with diameters between 15–31 mm and 0.978 for targets with diameters less than 15 mm.

Conclusion

The agreement of PD to TPS mean dose in the high dose region was found to be dependent on target size. Film measurements did not exhibit size dependence. All PD plans passed the 3%/2 mm gamma analysis, but caution should be used when using PD to assess overall dosimetric accuracy of the treatment plan for small targets.

Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy

Purpose

To assess the long‐term stability of the anchored radiofrequency transponders and compare displacement rates with other commercially available lung fiducial markers. We also sought to describe late toxicity attributable to fiducial implantation or migration.

Materials and methods

The transponder cohort was comprised of 17 patients at our institution who enrolled in a multisite prospective clinical trial and underwent bronchoscopic implantation of three anchored transponders into small (2–2.5 mm) airways. We generated a comparison cohort of 34 patients by selecting patients from our institutional lung SBRT database and matching 2:1 based on the lobe containing tumor and proximity to the bronchial tree. Assessment of migration was performed by rigidly registering the most recent follow‐up CT scan to the simulation scan, and assessing whether the relative geometry of the fiducial markers had changed by more than 5 mm. Toxicity outcomes of interest were hemoptysis and pneumothorax.

Results

The median follow‐up of patients in the transponder cohort was 25.3 months and the median follow‐up in the comparison cohort was 21.7 months. When assessing the most recent CT, all fiducial markers were within 5 mm of their position at CT simulation in 11 (65%) patients in the transponder group as compared to 23 (68%) in the comparison group (P = 0.28). One case of hemoptysis was identified in the transponder cohort, and bronchoscopy confirmed bleeding from recurrent tumor; no cases of hemoptysis were noted in the comparison cohort. No case of pneumothorax was noted in either group.

Conclusion

No significant difference in the rates of fiducial marker retention and migration were noted when comparing patients who had anchored transponders placed into small airways and a 2:1 matched cohort of patients who had other commercially available lung fiducial markers placed. In both groups, no late or chronic toxicity appeared to be related to the implanted fiducial markers.

The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery

Purpose

The study aimed to develop and demonstrate a standardized linear accelerator multileaf collimator-based method of delivering small, spherical dose distributions suitable for radiosurgical treatment of small targets such as the trigeminal nerve.

Methods and materials

The virtual cone is composed of a multileaf collimator–defined field with the central 2 leaves set to a small gap. For 5 table positions, clockwise and counter-clockwise arcs were used with collimator angles of 45 and 135 degrees, respectively. The dose per degree was proportional to the sine of the gantry angle. The dose distribution was calculated by the treatment planning system and measured using radiochromic film in a skull phantom for leaf gaps of 1.6, 2.1, and 2.6 mm. Cones with a diameter of 4 mm and 5 mm were measured for comparison. Output factor constancy was investigated using a parallel-plate chamber.

Results

The mean ratio of the measured-to-calculated dose was 0.99, 1.03, and 1.05 for 1.6, 2.1, and 2.6 mm leaf gaps, respectively. The diameter of the measured (calculated) 50% isodose line was 4.9 (4.6) mm, 5.2 (5.1) mm, and 5.5 (5.5) mm for the 1.6, 2.1, and 2.6 mm leaf gap, respectively. The measured diameter of the 50% isodose line was 4.5 and 5.7 mm for the 4 mm and 5 mm cones, respectively. The standard deviation of the parallel-plate chamber signal relative to a 10 cm × 10 cm field was less than 0.4%. The relative signal changed 32% per millimeter change in leaf gap, indicating that the parallel-plate chamber is sensitive to changes in gap width.

Conclusions

The virtual cone is an efficient technique for treatment of small spherical targets. Patient-specific quality assurance measurements will not be necessary in routine clinical use. Integration directly into the treatment planning system will make planning using this technique extremely efficient.

Evaluation of multiple factors affecting normal brain dose in single-isocenter multiple target radiosurgery

We investigated the effects of multiple planning factors on normal brain dose for single-isocenter VMAT stereotactic radiosurgery (SRS). Ten patients were retrospectively planned using a standardized objective function and all 16 combinations of 2 versus 4 arcs, collimator angle 45° versus selected per beam to minimize area of normal brain exposed in the beams-eye-view, fixed jaw versus following the trailing MLC leaf, and a 2 Gy mean dose objective for healthy brain versus no low dose objective. Limiting the normal brain mean dose in the optimization objective function significantly reduced the low dose spill into the normal brain without changing target coverage. Jaw tracking and appropriate selection of collimator also reduced the low dose volume, but to a lesser extent. To reduce low dose spill into normal brain for single isocenter VMAT radiosurgery of multiple targets, it is important to incorporate a limit on low dose spill into the objective function. This study has implications beyond single-isocenter VMAT radiosurgery. When comparing different inverse-planned treatment techniques, metrics that are important for evaluation of plan quality must be included the objective function.

Fractionated stereotactic radiation therapy for intact brain metastases

Purpose

Limited data exist on fractionated stereotactic radiation therapy (FSRT) for brain metastases. We sought to evaluate the safety and efficacy of FSRT and further define its role in brain metastasis management.

Methods and materials

A total of 72 patients were treated with linear accelerator–based FSRT to 182 previously untreated, intact brain metastases. Targets received 25 or 30 Gy in 5 fractions. All targets within the same course received the same prescription regardless of size. Toxicity was recorded per Radiation Therapy Oncology Group central nervous system toxicity criteria.

Results

The median follow-up was 5 months (range, 1-71 months). The Kaplan-Meier estimate of 12-month local control was 86%. Tumors <3 cm in diameter demonstrated improved 12-month local control of 95% compared with 61% in tumors ≥3 cm (P < .001). The Kaplan-Meier estimate of 12-month local control was 91% in tumors treated with 30 Gy and only 75% in tumors treated with 25 Gy (P = .015). Tumor diameter ≥3 cm resulted in increased local failure, and a 30 Gy prescription resulted in decreased local failure on multivariate analysis (hazard ratio [HR], 8.11 [range, 2.09-31.50; P = .003] and HR, 0.26 [range, 0.07-0.93; P = .038]). Grade 4 central nervous system toxicity occurred in 4 patients (6%) requiring surgery, and no patient experienced irreversible grade 3 or 5 toxicity. Increasing tumor diameter was associated with increased toxicity risk (HR, 2.45 [range, 1.04-5.742; P = .04]).

Conclusions

FSRT for brain metastases appears to demonstrate a high rate of local control with minimal risk of severe toxicity. Local control appears to be associated with smaller tumor sizeand a higher prescription dose. FSRT is a viable option for those who are poor single-fraction candidates.

A priori patient-specific collision avoidance in radiotherapy using consumer grade depth cameras

PURPOSE

In this study, we demonstrate and evaluate a low cost, fast, and accurate avoidance framework for radiotherapy treatments. Furthermore, we provide an implementation which is patient specific and can be implemented during the normal simulation process.

METHODS

Four patients and a treatment unit were scanned with a set of consumer depth cameras to create a polygon mesh of each object. Using a fast polygon interference algorithm, the models were virtually collided to map out feasible treatment positions of the couch and gantry. The actual physical collision space was then mapped in the treatment room by moving the gantry and couch until a collision occurred with either the patient or hardware. The physical and virtual collision spaces were then compared to determine the accuracy of the system. To improve the collision predictions, a buffer geometry was added to the scanned gantry mesh and performance was assessed as a function of buffer thickness.

RESULTS

Each patient was optically scanned during simulation in less than 1 min. The average time to virtually map the collision space for 64, 800 gantry/couch states was 5.40 ± 2.88 s. The system had an average raw accuracy and negative prediction rate (NPR) across all patients of 97.3% ± 2.4% and 96.9% ± 2.2% respectively. Using a polygon buffer of 6 cm over the gantry geometry, the NPR was raised to unity for all patients, signifying the detection of all collision events. However, the average accuracy fell from 95.3% ± 3.1% to 91.5% ± 3.6% between the 3 and 6 cm buffer as more false positives were detected.

CONCLUSIONS

We successfully demonstrated a fast and low cost framework which can map an entire collision space a priori for a given patient during the time of simulation. All collisions can be avoided using polygon interference, but a polygon buffer may be required to account for geometric uncertainties of scanned objects.

A novel phantom and procedure providing submillimeter accuracy in daily QA tests of accelerators used for stereotactic radiosurgery*

Stereotactic radiosurgery (SRS) places great demands on spatial accuracy. Steel BBs used as markers in quality assurance (QA) phantoms are clearly visible in MV and planar kV images, but artifacts compromise cone‐beam CT (CBCT) isocenter localization. The purpose of this work was to develop a QA phantom for measuring with sub‐mm accuracy isocenter congruence of planar kV, MV, and CBCT imaging systems and to design a practical QA procedure that includes daily Winston‐Lutz (WL) tests and does not require computer aid. The salient feature of the phantom (Universal Alignment Ball (UAB)) is a novel marker for precisely localizing isocenters of CBCT, planar kV, and MV beams. It consists of a 25.4 mm diameter sphere of polymethylmetacrylate (PMMA) containing a concentric 6.35 mm diameter tungsten carbide ball. The large density difference between PMMA and the polystyrene foam in which the PMMA sphere is embedded yields a sharp image of the sphere for accurate CBCT registration. The tungsten carbide ball serves in finding isocenter in planar kV and MV images and in doing WL tests. With the aid of the UAB, CBCT isocenter was located within 0.10±0.05 mm of its true positon, and MV isocenter was pinpointed in planar images to within 0.06±0.04 mm. In clinical morning QA tests extending over an 18 months period the UAB consistently yielded measurements with sub‐mm accuracy. The average distance between isocenter defined by orthogonal kV images and CBCT measured 0.16±0.12 mm. In WL tests the central ray of anterior beams defined by a 1.5×1.5 cm2 MLC field agreed with CBCT isocenter within 0.03±0.14 mm in the lateral direction and within 0.10±0.19 mm in the longitudinal direction. Lateral MV beams approached CBCT isocenter within 0.00±0.11 mm in the vertical direction and within ‐0.14±0.15 mm longitudinally. It took therapists about 10 min to do the tests. The novel QA phantom allows pinpointing CBCT and MV isocenter positions to better than 0.2 mm, using visual image registration. Under CBCT guidance, MLC‐defined beams are deliverable with sub‐mm spatial accuracy. The QA procedure is practical for daily tests by therapists.

PACS number(s): 87.53.Ly, 87.56.Fc

Implementation of Talairach Atlas Based Automated Brain Segmentation for Radiation Therapy Dosimetry

Radiotherapy for brain cancer inevitably results in irradiation of uninvolved brain. While it has been demonstrated that irradiation of the brain can result in cognitive deficits, dose-volume relationships are not well established. There is little work correlating a particular cognitive deficit with dose received by the region of the brain responsible for the specific cognitive function. One obstacle to such studies is that identification of brain anatomy is both labor intensive and dependent on the individual performing the segmentation. Automatic segmentation has the potential to be both efficient and consistent. Brains2 is a software package developed by the University of Iowa for MRI volumetric studies. It utilizes MR images, the Talairach atlas, and an artificial neural network (ANN) to segment brain images into substructures in a standardized manner. We have developed a software package, Brains2DICOM, that converts the regions of interest identified by Brains2 into a DICOM radiotherapy structure set. The structure set can be imported into a treatment planning system for dosimetry. We demonstrated the utility of Brains2DICOM using a test case, a 34-year-old man with diffuse astrocytoma treated with three-dimensional conformal radiotherapy. Brains2 successfully applied the Talairach atlas to identify the right and left frontal, parietal, temporal, occipital, subcortical, and cerebellum regions. Brains2 was not successful in applying the ANN to identify small structures, such as the hippocampus and caudate. Further work is necessary to revise the ANN or to develop new methods for identification of small structures in the presence of disease and radiation induced changes. The segmented regions-of-interest were transferred to our commercial treatment planning system using DICOM and dose-volume histograms were constructed. This method will facilitate the acquisition of data necessary for the development of normal tissue complication probability (NTCP) models that assess the probability of cognitive complications secondary to radiotherapy for intracranial and head and neck neoplasms.

Evaluation of the Eclipse eMC algorithm for bolus electron conformal therapy using a standard verification dataset

The purpose of this study was to evaluate the accuracy and calculation speed of electron dose distributions calculated by the Eclipse electron Monte Carlo (eMC) algorithm for use with bolus electron conformal therapy (ECT). The recent commercial availability of bolus ECT technology requires further validation of the eMC dose calculation algorithm. eMC‐calculated electron dose distributions for bolus ECT have been compared to previously measured TLD‐dose points throughout patient‐based cylindrical phantoms (retromolar trigone and nose), whose axial cross sections were based on the mid‐PTV (planning treatment volume) CT anatomy. The phantoms consisted of SR4 muscle substitute, SR4 bone substitute, and air. The treatment plans were imported into the Eclipse treatment planning system, and electron dose distributions calculated using 1% and <0.2% statistical uncertainties. The accuracy of the dose calculations using moderate smoothing and no smoothing were evaluated. Dose differences (eMC‐calculated less measured dose) were evaluated in terms of absolute dose difference, where 100% equals the given dose, as well as distance to agreement (DTA). Dose calculations were also evaluated for calculation speed. Results from the eMC for the retromolar trigone phantom using 1% statistical uncertainty without smoothing showed calculated dose at 89% (41/46) of the measured TLD‐dose points was within 3% dose difference or 3 mm DTA of the measured value. The average dose difference was −0.21%, and the net standard deviation was 2.32%. Differences as large as 3.7% occurred immediately distal to the mandible bone. Results for the nose phantom, using 1% statistical uncertainty without smoothing, showed calculated dose at 93% (53/57) of the measured TLD‐dose points within 3% dose difference or 3 mm DTA. The average dose difference was 1.08%, and the net standard deviation was 3.17%. Differences as large as 10% occurred lateral to the nasal air cavities. Including smoothing had insignificant effects on the accuracy of the retromolar trigone phantom calculations, but reduced the accuracy of the nose phantom calculations in the high‐gradient dose areas. Dose calculation times with 1% statistical uncertainty for the retromolar trigone and nose treatment plans were 30 s and 24 s, respectively, using 16 processors (Intel Xeon E5‐2690, 2.9 GHz) on a framework agent server (FAS). In comparison, the eMC was significantly more accurate than the pencil beam algorithm (PBA). The eMC has comparable accuracy to the pencil beam redefinition algorithm (PBRA) used for bolus ECT planning and has acceptably low dose calculation times. The eMC accuracy decreased when smoothing was used in high‐gradient dose regions. The eMC accuracy was consistent with that previously reported for accuracy of the eMC electron dose algorithm and shows that the algorithm is suitable for clinical implementation of bolus ECT.

PACS number(s): 87.55.kd

Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy

PURPOSE

The purpose of this study was to determine whether radiation dose inhomogeneity within the prostate predisposes to late urinary strictures after moderately hypofractionated definitive external beam radiation therapy for prostate cancer.

METHODS AND MATERIALS

One hundred seventy-three men with clinically localized prostate cancer met the inclusion criteria for this analysis. All patients received 70 Gy to the prostate delivered over 28 fractions, had at least 2 years of clinical follow-up, and had dose-volume histogram information available for review. The endpoint of this study was the development of a urethral stricture that required a procedural intervention such as urethral dilation or suprapubic catheterization. Dosimetric parameters were evaluated for effect on the rate of urethral stricture formation by univariate Cox proportional hazards modeling.

RESULTS

The median follow-up was 49.5 months (range, 24.6-108 months). At 5 years, the actuarial rate of intervention for urethral strictures across all patients was 4.9%. The maximum point dose within the prostate (P = .034, hazard ratio = 1.006) and the mean prostate dose (P = .039, hazard ratio = 1.004) were the only parameters predictive of urethral stricture formation. All patients who developed a urethral stricture were treated by a plan with a maximum prostate dose of >75 Gy (median, 77.67 Gy).

CONCLUSIONS

For patients receiving moderately hypofractionated prostate radiation therapy over 28 fractions, a maximum point dose of 75 Gy within the prostate was associated with an increased probability of developing a urethral stricture that required procedural intervention. The hypothesis that hypofractionation increases susceptibility to toxicity from heterogeneity within the prostate should be confirmed by analyzing data from randomized trials with a conventionally fractionated control arm for comparison.

Beam geometry selection using sequential beam addition

PURPOSE

The selection of optimal beam geometry has been of interest since the inception of conformal radiotherapy. The authors report on sequential beam addition, a simple beam geometry selection method, for intensity modulated radiation therapy.

METHODS

The sequential beam addition algorithm (SBA) requires definition of an objective function (score) and a set of candidate beam geometries (pool). In the first iteration, the optimal score is determined for each beam in the pool and the beam with the best score selected. In the next iteration, the optimal score is calculated for each beam remaining in the pool combined with the beam selected in the first iteration, and the best scoring beam is selected. The process is repeated until the desired number of beams is reached. The authors selected three treatment sites, breast, lung, and brain, and determined beam arrangements for up to 11 beams from a pool comprised of 25 equiangular transverse beams. For the brain, arrangements were additionally selected from a pool of 22 noncoplanar beams. Scores were determined for geometries comprised equiangular transverse beams (EQA), as well as two tangential beams for the breast case.

RESULTS

In all cases, SBA resulted in scores superior to EQA. The breast case had the strongest dependence on beam geometry, for which only the 7-beam EQA geometry had a score better than the two tangential beams, whereas all SBA geometries with more than two beams were superior. In the lung case, EQA and SBA scores monotonically improved with increasing number of beams; however, SBA required fewer beams to achieve scores equivalent to EQA. For the brain case, SBA with a coplanar pool was equivalent to EQA, while the noncoplanar pool resulted in slightly better scores; however, the dose-volume histograms demonstrated that the differences were not clinically significant.

CONCLUSIONS

For situations in which beam geometry has a significant effect on the objective function, SBA can identify arrangements equivalent to equiangular geometries but using fewer beams. Furthermore, SBA provides the value of the objective function as the number of beams is increased, allowing the planner to select the minimal beam number that achieves the clinical goals. The method is simple to implement and could readily be incorporated into an existing optimization system.